Logo image of MB

MASTERBEEF GROUP (MB) Stock Fundamental Analysis

NASDAQ:MB - Nasdaq - KYG6001H1011 - Common Stock - Currency: USD

14.8  +0.47 (+3.28%)

Fundamental Rating

1

Taking everything into account, MB scores 1 out of 10 in our fundamental rating. MB was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of MB have multiple concerns. MB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MB was profitable.
In the past year MB had a positive cash flow from operations.
MB Yearly Net Income VS EBIT VS OCF VS FCFMB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 10.67%
ROE 115.26%
ROIC N/A
ROA(3y)2.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MB Yearly ROA, ROE, ROICMB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 400 600 800

1.3 Margins

Industry RankSector Rank
OM N/A
PM (TTM) 6.53%
GM 63.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MB Yearly Profit, Operating, Gross MarginsMB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

MB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MB has been reduced compared to 1 year ago.
MB has a worse debt/assets ratio than last year.
MB Yearly Shares OutstandingMB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
MB Yearly Total Debt VS Total AssetsMB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 5.86 indicates that MB is not in any danger for bankruptcy at the moment.
MB has a debt to FCF ratio of 3.91. This is a good value and a sign of high solvency as MB would need 3.91 years to pay back of all of its debts.
MB has a Debt/Equity ratio of 2.25. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 3.91
Altman-Z 5.86
ROIC/WACCN/A
WACC6.73%
MB Yearly LT Debt VS Equity VS FCFMB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

MB has a Current Ratio of 0.83. This is a bad value and indicates that MB is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.73 indicates that MB may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.73
MB Yearly Current Assets VS Current LiabilitesMB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

MB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 216.28%, which is quite impressive.
The Revenue has decreased by -5.32% in the past year.
EPS 1Y (TTM)216.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%216.28%
Revenue 1Y (TTM)-5.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MB Yearly Revenue VS EstimatesMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.85, which means the current valuation is very expensive for MB.
When comparing the Price/Earnings ratio of MB to the average of the S&P500 Index (27.46), we can say MB is valued expensively.
Industry RankSector Rank
PE 44.85
Fwd PE N/A
MB Price Earnings VS Forward Price EarningsMB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 41.38
EV/EBITDA 27.67
MB Per share dataMB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MASTERBEEF GROUP

NASDAQ:MB (7/21/2025, 8:17:48 PM)

14.8

+0.47 (+3.28%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0.03%
Ins OwnersN/A
Ins Owner Change0%
Market Cap253.97M
AnalystsN/A
Price TargetN/A
Short Float %0.51%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 44.85
Fwd PE N/A
P/S 3.96
P/FCF 41.38
P/OCF 33.13
P/B 69.84
P/tB 69.84
EV/EBITDA 27.67
EPS(TTM)0.33
EY2.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.36
FCFY2.42%
OCF(TTM)0.45
OCFY3.02%
SpS3.74
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.67%
ROE 115.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.53%
GM 63.88%
FCFM 9.56%
ROA(3y)2.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 3.91
Debt/EBITDA 0.86
Cap/Depr 15.26%
Cap/Sales 2.38%
Interest Coverage N/A
Cash Conversion 80.64%
Profit Quality 146.43%
Current Ratio 0.83
Quick Ratio 0.73
Altman-Z 5.86
F-Score7
WACC6.73%
ROIC/WACCN/A
Cap/Depr(3y)38.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.95%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)216.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%216.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-185.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.77%
OCF growth 3YN/A
OCF growth 5YN/A